Technicals

Teekay Corporation (TK) in Focus: Stock Plunges 58.4%

Teekay Corporation TK saw a big move in the last trading session, as the company’s shares fell by over 58% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent trend for TK, as the stock is now down 74% in the past one-month time frame […]

Technicals

BlackBerry (BBRY) Reports Narrower Than Expected Q3 Loss

BlackBerry Limited BBRY designs, manufactures, and sells wireless solutions to the mobile communications market. Through the development and integration of hardware, software, and services, BlackBerry provides solutions for seamless access to time-sensitive information, including e-mail, messaging, as well as Internet and Intranet-based applications. Recently, BlackBerry launched its much-awaited Android-based handset PRIV […]

Technicals

Global Partners (GLP) Crumbles: Stock Goes Down 11.4%

Global Partners LP GLP saw a big move last session, as the company’s shares fell by over 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for GLP, as the stock is now down over 37% in the past one-month time frame […]

Technicals

Why Caesars Entertainment (CZR) Could Be Positioned for a Surge?

Caesars Entertainment Corporation CZR provides casino-entertainment and hospitality services that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well. These positive earnings estimate revisions suggest that analysts are becoming more optimistic on CZR’s earnings for the coming quarter and year […]

Mergers & Acquisitions

Mallinckrodt Diversifies Hospital Growth Portfolio, Acquiring Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company

Mallinckrodt Diversifies Hospital Growth Portfolio, Acquiring Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company — Mallinckrodt will invest in market development of RECOTHROM, PreveLeak™ and RAPLIXA™ – innovative, highly durable hemostasis products that increase surgeons’ choice – — Addition of global hemostasis assets will augment Mallinckrodt’s growing hospital portfolio, including INOmax and THERAKOS; specifically expands on current OFIRMEV surgical pain management offering — — Approved for use in the U.S. and certain European countries with long-range market exclusivity through intellectual property protection – RECOTHROM, 2026; PreveLeak, 2028; RAPLIXA, 2031 — — Upfront payment of approximately $175 million inclusive of existing inventory; transaction also includes potential future added milestone payments and is expected to be financed from cash on hand — –Transaction expected to be accretive in fiscal 2017, driving organic growth for these products in the low double-digits — PR Newswire CHESTERFIELD, United Kingdom, Dec. 18, 2015 CHESTERFIELD, United Kingdom , Dec […]

Technicals

Lennar (LEN) Beats on 4Q Earnings, Revenue Miss

Lennar Corporation LEN is one of the leading homebuilders in the U.S. With overall housing market recovering at a slow but steady pace, Lennar’s order trends have been improving at a consistent pace. Lennar is performing well on the back of its diverse revenue mix, large land supply, above average order growth and better pricing power […]